Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-073-9 | CAS number: 20837-86-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: study was preformed according to GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Lead cyanamidate
- EC Number:
- 244-073-9
- EC Name:
- Lead cyanamidate
- Cas Number:
- 20837-86-9
- Molecular formula:
- CN2.Pb
- IUPAC Name:
- λ²-lead(2+) (azanidylenemethylidene)azanide
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- Test system Mice, CBA/CaOlaHsd
Rationale Recognised as the recommended test system.
Source Harlan Laboratories B.V.
Postbus 6174
5960 AD Horst / The Netherlands
Number of animals for the pre-test 2 females
Number of animals for the main study 16 females (reserve animals will be used as needed and listed in raw data and report)
Number of animals per group 4 females (nulliparous and non-pregnant)
Number of test groups 3
Number of control (vehicle) group 1
(If possible, concurrent controls will be used for several Harlan CCR projects performed in parallel to save animals).
Age 8 - 12 weeks (beginning of treatment)
Body weight 15 - 25 g (beginning of treatment)
Identification
The animals will be distributed into the test groups at random. All animals belonging to the same experimental group will be kept in one cage. In the main experiment, the animals will be identified by tail tags. In the pre-experiment, animals will be identified by cage number.
Acclimatisation
At least 5 days prior to the start of dosing under test conditions after health examination. Only animals without any visible signs of illness will be used for the study.
Study design: in vivo (non-LLNA)
- Positive control substance(s):
- no
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- The highest test item concentration, which can be technically used was a 25 % (w/w) suspension in acetone:olive oil (4+1 v/v) after vortexing.
To determine the highest non-irritant test concentration that does at the same time not induce signs of systemic toxicity, a pre-test will be performed in two animals and stated in raw data and report. Two mice will be treated by (epidermal) topical application to the dorsal surface of each ear with test item concentrations of 10 and 25% once daily each on three consecutive days. Prior to the first application of the test item and before sacrifice the body weight will be determined. Clinical signs will be recorded at least once daily. Eventual signs of local irritation will be documented and a score will be used to grade a possible reddening of the ear skin. Furthermore, prior to the first application of the test item (day 1), on day 3 and before sacrifice (day 6) the ear thickness will be determined using a micrometer (S0247 Kroeplin, 36381 Schlüchtern, Germany). Additionally, for both animals, the ears will be punched after sacrifice (day 6) at the apical area using a biopsy punch (Stiefel, Ø 8 mm corresponding to 0.5 cm2) and will be immediately pooled per animal and weighed using an analytical balance. The results of the observations and measurements will be described in the report. Eventual ear irritation is considered to be excessive if reddening of the ear skin of a score value ≥3 is observed at any observation time and/or if an increase in ear thickness of ≥25% is recorded on day 3 or day 6. In case of induction of excessive irritation or systemic toxicity the chosen concentration range will shift to lower levels and will be described in the report.
The test item in the main study will be assayed at three consecutive concentrations. The highest concentration to be tested will be the highest level that can be achieved whilst avoiding systemic toxicity and excessive local irritation in the pre-experiment. - No. of animals per dose:
- 4 animals
Results and discussion
In vivo (LLNA)
Results
- Parameter:
- SI
- Remarks on result:
- other: see any other information on results incl. tables
Any other information on results incl. tables
Test item Name: | Cyanamide, lead(2+) salt (1:1) | |||||
Vehicle: | A:OO | |||||
Stimulation Index: | ||||||
Test item concentration % (w/v) | Measurement DPM | Calculation | Result | |||
DPM-BGa) | number of lymph nodes | DPM per lymph nodeb) | S.I. | |||
--- | BG I | 18 | --- | --- | --- | --- |
--- | BG II | 41 | --- | --- | --- | --- |
NK | 1 | 2251 | 2222 | 8 | 277,7 | 1,00 |
5% | 2 | 3589 | 3560 | 8 | 444,9 | 1,60 |
10% | 3 | 4154 | 4125 | 8 | 515,6 | 1,86 |
25% | 4 | 16136 | 16107 | 8 | 2013,3 | 7,25 |
EC3-Berechnung: | ||||||
C | S.I. | EC3 | ||||
% (w/v) | % (w/v) | |||||
Konzentration | S.I. | |||||
SI < 3 | (a) | 10 | (b) | 1,86 | 13,2 | |
SI >3 | (c) | 25 | (d) | 7,25 | ||
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- The presented data are reliable and adequate.
- Executive summary:
The substance Cyanamide, lead(2+) salt (1:1) can be regarded as sensitising.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.